Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inovio Pharmaceuticals, Inc. (INO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inovio Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1055726.
Total stock buying since 2015: $1,145,079.
Total stock sales since 2015: $19,261,164.
Total stock option exercises since 2015: $4,688,327.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 72,895 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 64,899 | $0 |
| 2023 | 0 | $0 | 23,201 | $24,834 | 460,211 | $0 |
| 2022 | 0 | $0 | 39,602 | $107,100 | 802,416 | $38,850 |
| 2021 | 0 | $0 | 397,200 | $4,884,842 | 918,102 | $898,649 |
| 2020 | 22,500 | $69,975 | 287,554 | $5,464,899 | 602,695 | $249,649 |
| 2019 | 24,500 | $59,990 | 2,382,673 | $5,873,525 | 472,785 | $0 |
| 2018 | 0 | $0 | 318,061 | $1,611,908 | 756,255 | $877,376 |
| 2017 | 21,300 | $133,188 | 155,180 | $1,026,498 | 585,141 | $1,119,260 |
| 2016 | 78,400 | $740,426 | 28,050 | $267,558 | 366,336 | $1,504,543 |
| 2015 | 18,000 | $141,500 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 0 | $0 | 2,916 | $0 |
| 2025-05 | 0 | $0 | 0 | $0 | 20,669 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 49,310 | $0 |
| 2024-06 | 0 | $0 | 0 | $0 | 2,917 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 51,335 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 10,647 | $0 |
| 2023-06 | 0 | $0 | 5,700 | $3,192 | 35,000 | $0 |
| 2023-05 | 0 | $0 | 0 | $0 | 211,000 | $0 |
| 2023-03 | 0 | $0 | 5,833 | $6,707 | 190,877 | $0 |
| 2023-02 | 0 | $0 | 11,668 | $14,935 | 23,334 | $0 |
| 2022-08 | 0 | $0 | 11,875 | $31,587 | 11,875 | $25,650 |
| 2022-07 | 0 | $0 | 2,000 | $4,500 | 2,000 | $4,400 |
| 2022-05 | 0 | $0 | 12,600 | $24,678 | 120,000 | $0 |
| 2022-03 | 0 | $0 | 10,166 | $32,981 | 589,410 | $4,400 |
| 2022-02 | 0 | $0 | 0 | $0 | 68,767 | $0 |
| 2022-01 | 0 | $0 | 2,961 | $13,354 | 10,364 | $4,400 |
| 2021-08 | 0 | $0 | 10,317 | $94,400 | 0 | $0 |
| 2021-06 | 0 | $0 | 54,068 | $511,721 | 13,750 | $29,700 |
| 2021-05 | 0 | $0 | 2,045 | $13,537 | 17,400 | $0 |
| 2021-04 | 0 | $0 | 28,583 | $244,917 | 24,500 | $61,120 |
| 2021-03 | 0 | $0 | 30,591 | $298,623 | 656,838 | $7,120 |
| 2021-02 | 0 | $0 | 192,836 | $2,845,250 | 86,876 | $373,121 |
| 2021-01 | 0 | $0 | 78,760 | $876,394 | 118,738 | $427,588 |
| 2020-12 | 0 | $0 | 37,500 | $401,055 | 41,590 | $125,399 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | Sumner Michael John (Chief Medical Officer) | Option Ex | 2,916 | .00 | 0 |
| 2025-05-21 | Miller Ann Calby (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-21 | Dansey Roger D (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-21 | Weiner David B. (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-21 | Shepard Jay (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-21 | Zoth Lota S. (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-21 | Benito Simon X (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-21 | Yarno Wendy L (Director) | Option Ex | 2,167 | .00 | 0 |
| 2025-05-10 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 5,500 | .00 | 0 |
| 2025-02-26 | Sumner Michael John (Chief Medical Officer) | Option Ex | 5,010 | .00 | 0 |
| 2025-02-26 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 24,484 | .00 | 0 |
| 2025-02-26 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 8,865 | .00 | 0 |
| 2025-02-26 | Weiner David B. (Director) | Option Ex | 1,944 | .00 | 0 |
| 2025-02-26 | Kies Peter (CFO) | Option Ex | 9,007 | .00 | 0 |
| 2024-06-30 | Sumner Michael John (Chief Medical Officer) | Option Ex | 2,917 | .00 | 0 |
| 2024-05-15 | Sumner Michael John (Chief Medical Officer) | Option Ex | 2,386 | .00 | 0 |
| 2024-05-15 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 17,745 | .00 | 0 |
| 2024-05-15 | Miller Ann Calby (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-15 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 4,771 | .00 | 0 |
| 2024-05-15 | Dansey Roger D (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-15 | Weiner David B. (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-15 | Shepard Jay (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-15 | Zoth Lota S. (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-15 | Benito Simon X (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-15 | Kies Peter (CFO) | Option Ex | 4,771 | .00 | 0 |
| 2024-05-15 | Yarno Wendy L (Director) | Option Ex | 2,166 | .00 | 0 |
| 2024-05-13 | Dansey Roger D (Director) | Option Ex | 1,000 | .00 | 0 |
| 2024-05-10 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 5,500 | .00 | 0 |
| 2024-02-26 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 7,731 | .00 | 0 |
| 2024-02-26 | Weiner David B. (Director) | Option Ex | 2,916 | .00 | 0 |
| 2023-06-30 | Sumner Michael John (Chief Medical Officer) | Option Ex | 35,000 | .00 | 0 |
| 2023-06-05 | Zoth Lota S. (Director) | Sale | 5,700 | .56 | 3,192 |
| 2023-05-16 | Miller Ann Calby (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-16 | Dansey Roger D (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-16 | Weiner David B. (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-16 | Shepard Jay (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-16 | Zoth Lota S. (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-16 | Benito Simon X (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-16 | Yarno Wendy L (Director) | Option Ex | 19,000 | .00 | 0 |
| 2023-05-13 | Dansey Roger D (Director) | Option Ex | 12,000 | .00 | 0 |
| 2023-05-10 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 66,000 | .00 | 0 |
| 2023-03-13 | Weiner David B. | Sale | 5,833 | 1.15 | 6,707 |
| 2023-03-11 | Shea Jacqueline Elizabeth (Chief Executive Officer) | Option Ex | 59,737 | .00 | 0 |
| 2023-03-11 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 59,737 | .00 | 0 |
| 2023-03-11 | Weiner David B. | Option Ex | 11,666 | .00 | 0 |
| 2023-03-11 | Kies Peter (CFO) | Option Ex | 59,737 | .00 | 0 |
| 2023-02-27 | Weiner David B. | Sale | 11,668 | 1.28 | 14,935 |
| 2023-02-26 | Weiner David B. | Option Ex | 23,334 | .00 | 0 |
| 2022-08-11 | Weiner David B. | Sale | 11,875 | 2.66 | 31,587 |
| 2022-08-11 | Weiner David B. | Option Ex | 11,875 | 2.16 | 25,650 |
| 2022-07-20 | Benito Simon X | Sale | 2,000 | 2.25 | 4,500 |
| 2022-07-20 | Benito Simon X | Option Ex | 2,000 | 2.20 | 4,400 |
| 2022-05-16 | Weiner David B. | Sale | 9,000 | 1.95 | 17,550 |
| 2022-05-16 | Zoth Lota S. | Sale | 3,600 | 1.98 | 7,128 |
| 2022-05-13 | Miller Ann Calby | Option Ex | 18,000 | .00 | 0 |
| 2022-05-13 | Dansey Roger D | Option Ex | 12,000 | .00 | 0 |
| 2022-05-13 | Weiner David B. | Option Ex | 18,000 | .00 | 0 |
| 2022-05-13 | Shepard Jay | Option Ex | 18,000 | .00 | 0 |
| 2022-05-13 | Zoth Lota S. | Option Ex | 18,000 | .00 | 0 |
| 2022-05-13 | Benito Simon X | Option Ex | 18,000 | .00 | 0 |
| 2022-05-13 | Yarno Wendy L | Option Ex | 18,000 | .00 | 0 |
| 2022-03-25 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 16,666 | .00 | 0 |
| 2022-03-21 | Miller Ann Calby | Option Ex | 4,273 | .00 | 0 |
| 2022-03-16 | Benito Simon X | Sale | 2,000 | 3.16 | 6,320 |
| 2022-03-16 | Benito Simon X | Option Ex | 2,000 | 2.20 | 4,400 |
| 2022-03-14 | Weiner David B. | Sale | 4,083 | 3.20 | 13,065 |
| 2022-03-11 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 59,737 | .00 | 0 |
| 2022-03-11 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 119,474 | .00 | 0 |
| 2022-03-11 | Weiner David B. | Option Ex | 11,667 | .00 | 0 |
| 2022-03-11 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 139,387 | .00 | 0 |
| 2022-03-11 | Kies Peter (CFO) | Option Ex | 59,737 | .00 | 0 |
| 2022-03-09 | Weiner David B. | Sale | 4,083 | 3.33 | 13,596 |
| 2022-03-08 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 19,900 | .00 | 0 |
| 2022-03-08 | Weiner David B. | Option Ex | 11,666 | .00 | 0 |
| 2022-03-08 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 63,700 | .00 | 0 |
| 2022-03-08 | Kies Peter (CFO) | Option Ex | 21,466 | .00 | 0 |
| 2022-02-26 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 68,767 | .00 | 0 |
| 2022-01-19 | Benito Simon X | Sale | 2,000 | 4.27 | 8,540 |
| 2022-01-19 | Benito Simon X | Option Ex | 2,000 | 2.20 | 4,400 |
| 2022-01-15 | Shepard Jay | Option Ex | 4,274 | .00 | 0 |
| 2022-01-05 | Zoth Lota S. | Sale | 961 | 5.01 | 4,814 |
| 2022-01-03 | Zoth Lota S. | Option Ex | 4,090 | .00 | 0 |
| 2021-08-09 | Humeau Laurent (Chief Scientific Officer) | Sale | 10,317 | 9.15 | 94,400 |
| 2021-06-09 | Humeau Laurent (Chief Scientific Officer) | Sale | 10,318 | 9.07 | 93,584 |
| 2021-06-09 | Kies Peter (CFO) | Sale | 33,750 | 10.01 | 337,837 |
| 2021-06-09 | Kies Peter (CFO) | Option Ex | 13,750 | 2.16 | 29,700 |
| 2021-06-03 | Kies Peter (CFO) | Sale | 10,000 | 8.03 | 80,300 |
| 2021-05-17 | Zoth Lota S. | Sale | 2,045 | 6.62 | 13,537 |
| 2021-05-14 | Miller Ann Calby | Option Ex | 8,700 | .00 | 0 |
| 2021-05-14 | Zoth Lota S. | Option Ex | 8,700 | .00 | 0 |
| 2021-04-21 | Weiner David B. | Sale | 26,583 | 8.55 | 227,417 |
| 2021-04-21 | Weiner David B. | Option Ex | 22,500 | 2.40 | 54,000 |
| 2021-04-16 | Benito Simon X | Sale | 2,000 | 8.75 | 17,500 |
| 2021-04-16 | Benito Simon X | Option Ex | 2,000 | 3.56 | 7,120 |
| 2021-03-26 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Sale | 4,710 | 8.97 | 42,248 |
| 2021-03-25 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 16,667 | .00 | 0 |
| 2021-03-21 | Miller Ann Calby | Option Ex | 4,274 | .00 | 0 |
| 2021-03-16 | Benito Simon X | Sale | 2,000 | 10.41 | 20,820 |
| 2021-03-16 | Benito Simon X | Option Ex | 2,000 | 3.56 | 7,120 |
| 2021-03-12 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Sale | 16,881 | 10.06 | 169,822 |
| 2021-03-11 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 59,737 | .00 | 0 |
| 2021-03-11 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 59,737 | .00 | 0 |
| 2021-03-11 | Weiner David B. | Option Ex | 11,667 | .00 | 0 |
| 2021-03-11 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 139,387 | .00 | 0 |
| 2021-03-11 | Kies Peter (CFO) | Option Ex | 59,737 | .00 | 0 |
| 2021-03-09 | Weiner David B. | Sale | 3,500 | 9.60 | 33,600 |
| 2021-03-08 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 19,900 | .00 | 0 |
| 2021-03-08 | Weiner David B. | Sale | 3,500 | 9.18 | 32,133 |
| 2021-03-08 | Weiner David B. | Option Ex | 11,667 | .00 | 0 |
| 2021-03-08 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 63,700 | .00 | 0 |
| 2021-03-08 | Kies Peter (CFO) | Option Ex | 21,467 | .00 | 0 |
| 2021-03-05 | Humeau Laurent (Chief Scientific Officer) | Option Ex | 27,566 | .00 | 0 |
| 2021-03-05 | Weiner David B. | Option Ex | 11,666 | .00 | 0 |
| 2021-03-05 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 120,100 | .00 | 0 |
| 2021-03-05 | Kies Peter (CFO) | Option Ex | 27,566 | .00 | 0 |
| 2021-02-16 | Benito Simon X | Sale | 2,000 | 14.68 | 29,360 |
| 2021-02-16 | Benito Simon X | Option Ex | 2,000 | 3.56 | 7,120 |
| 2021-02-03 | Kim Jong Joseph (Chief Executive Officer) | Sale | 62,500 | 14.24 | 890,000 |
| 2021-02-03 | Kim Jong Joseph (Chief Executive Officer) | Option Ex | 62,500 | 4.56 | 285,000 |
| 2021-02-01 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Sale | 28,336 | 15.03 | 425,890 |
| 2021-02-01 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 22,376 | 3.62 | 81,001 |
| 2021-02-01 | Kim Jong Joseph (Chief Executive Officer) | Sale | 100,000 | 15.00 | 1,500,000 |
| 2021-01-28 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Sale | 16,713 | 12.04 | 201,224 |
| 2021-01-28 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 55,248 | 3.62 | 199,997 |
| 2021-01-27 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Sale | 28,336 | 12.03 | 340,740 |
| 2021-01-27 | Shea Jacqueline Elizabeth (Chief Operating Officer) | Option Ex | 22,376 | 3.62 | 81,001 |
| 2021-01-15 | Shepard Jay | Option Ex | 4,274 | .00 | 0 |
| 2021-01-15 | Kies Peter (CFO) | Sale | 30,000 | 10.02 | 300,570 |
| 2021-01-15 | Kies Peter (CFO) | Option Ex | 30,000 | 4.56 | 136,800 |
| 2021-01-05 | Zoth Lota S. | Sale | 961 | 9.48 | 9,110 |
| 2021-01-04 | Benito Simon X | Sale | 2,750 | 9.00 | 24,750 |
| 2021-01-04 | Benito Simon X | Option Ex | 2,750 | 3.56 | 9,790 |
| 2021-01-03 | Zoth Lota S. | Option Ex | 4,090 | .00 | 0 |
| 2020-12-15 | Weiner David B. | Sale | 17,500 | 10.71 | 187,355 |
| 2020-12-15 | Weiner David B. | Option Ex | 17,500 | 4.56 | 79,800 |
| 2020-12-15 | Kies Peter (CFO) | Sale | 20,000 | 10.69 | 213,700 |
| 2020-12-15 | Kies Peter (CFO) | Option Ex | 20,000 | 2.28 | 45,599 |
| 2020-12-05 | Yarno Wendy L | Option Ex | 4,090 | .00 | 0 |
| 2020-11-10 | Humeau Laurent (Chief Scientific Officer) | Sale | 19,466 | 9.75 | 189,793 |
| 2020-08-10 | Humeau Laurent (Chief Scientific Officer) | Sale | 19,467 | 19.06 | 371,002 |
| 2020-07-30 | Kim Jong Joseph (Chief Executive Officer) | Sale | 100,000 | 21.14 | 2,113,500 |
| 2020-07-15 | Kies Peter (CFO) | Sale | 35,000 | 24.95 | 873,215 |
| 2020-07-15 | Kies Peter (CFO) | Option Ex | 35,000 | 2.40 | 84,000 |
| 2020-06-30 | Kies Peter (CFO) | Sale | 35,000 | 26.50 | 927,500 |
| 2020-06-22 | Humeau Laurent (Chief Scientific Officer) | Sale | 19,467 | 14.70 | 286,164 |
| 2020-05-20 | Benito Simon X | Sale | 8,750 | 15.95 | 139,597 |
| 2020-05-20 | Benito Simon X | Option Ex | 8,750 | 4.60 | 40,250 |
| 2020-05-11 | Weiner David B. | Sale | 2,404 | 11.84 | 28,463 |
| 2020-05-08 | Miller Ann Calby | Option Ex | 8,013 | .00 | 0 |
| 2020-05-08 | Weiner David B. | Option Ex | 8,013 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of INO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inovio Pharmaceuticals, Inc. (symbol INO, CIK number 1055726) see the Securities and Exchange Commission (SEC) website.